메뉴 건너뛰기




Volumn 121, Issue 4, 2010, Pages 308-314

Do the old psychostimulant drugs have a role in managing treatment-resistant depression?

Author keywords

Dexamphetamine; Methylphenidate; Stimulant monotherapy and augmentation; Treatment resistant depression

Indexed keywords

DEXAMPHETAMINE; METHYLPHENIDATE; SERTRALINE; VENLAFAXINE;

EID: 77949708788     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2009.01434.x     Document Type: Article
Times cited : (40)

References (17)
  • 1
    • 33644522035 scopus 로고    scopus 로고
    • Modafinil augmentation of SSRI therapy in patients with major depressive disorder and excessive sleepiness and fatigue: A 12 week, open-label, extension study
    • Thase ME, Fava M, Debattista C et al. Modafinil augmentation of SSRI therapy in patients with major depressive disorder and excessive sleepiness and fatigue: a 12 week, open-label, extension study. CNS Spectrums 2006 11 : 93 102.
    • (2006) CNS Spectrums , vol.11 , pp. 93-102
    • Thase, M.E.1    Fava, M.2    Debattista, C.3
  • 2
    • 34548102009 scopus 로고    scopus 로고
    • A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression
    • Frye MA, Grunze H, Suppes T et al. A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression. Am J Psychiatry 2007 164 : 1242 1249.
    • (2007) Am J Psychiatry , vol.164 , pp. 1242-1249
    • Frye, M.A.1    Grunze, H.2    Suppes, T.3
  • 3
    • 33947272977 scopus 로고    scopus 로고
    • Psychostimulants in the treatment of depression. A Review of the Evidence. Review Article
    • Orr K, Taylor D. Psychostimulants in the treatment of depression. A Review of the Evidence. Review Article. CNS Drugs 2007 21 : 239 257.
    • (2007) CNS Drugs , vol.21 , pp. 239-257
    • Orr, K.1    Taylor, D.2
  • 5
    • 0021945989 scopus 로고
    • Combined MAOI, TCA, and direct stimulant therapy of treatment-resistant depression
    • Feighner JP, Herbstein J, Damlouji N. Combined MAOI, TCA, and direct stimulant therapy of treatment-resistant depression. J Clin Psychiatry 1985 46 : 206 209.
    • (1985) J Clin Psychiatry , vol.46 , pp. 206-209
    • Feighner, J.P.1    Herbstein, J.2    Damlouji, N.3
  • 6
    • 0025860023 scopus 로고
    • CNS stimulant potentiation of monoamine oxidase inhibitors in treatment-refractory depression
    • Fawcett J, Kravitz HM, Zajecka JM et al. CNS stimulant potentiation of monoamine oxidase inhibitors in treatment-refractory depression. J Clin Psychopharm 1991 11 : 127 132.
    • (1991) J Clin Psychopharm , vol.11 , pp. 127-132
    • Fawcett, J.1    Kravitz, H.M.2    Zajecka, J.M.3
  • 7
    • 0030022134 scopus 로고    scopus 로고
    • Methylphenidate augmentation of serotonin selective reuptake inhibitors: A case series
    • Stoll AL, Pillay SS, Diamond L et al. Methylphenidate augmentation of serotonin selective reuptake inhibitors: a case series. J Clin Psychiatry 1996 57 : 72 76.
    • (1996) J Clin Psychiatry , vol.57 , pp. 72-76
    • Stoll, A.L.1    Pillay, S.S.2    Diamond, L.3
  • 8
    • 0026167906 scopus 로고
    • Combination of fluoxetine with pemoline in the treatment of major depressive disorder
    • Metz A, Shader RI. Combination of fluoxetine with pemoline in the treatment of major depressive disorder. Int Clin Psychopharmacol 1991 6 : 93 96.
    • (1991) Int Clin Psychopharmacol , vol.6 , pp. 93-96
    • Metz, A.1    Shader, R.I.2
  • 9
    • 33751112745 scopus 로고    scopus 로고
    • A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression
    • Patkar AA, Masand PS, Pae CU et al. A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression. J Clin Psychopharmacol 2006 26 : 653 656.
    • (2006) J Clin Psychopharmacol , vol.26 , pp. 653-656
    • Patkar, A.A.1    Masand, P.S.2    Pae, C.U.3
  • 10
    • 39549119969 scopus 로고    scopus 로고
    • Osmotic-release oral system methylphenidate augmentation of antidepressant monotherapy in major depressive disorder: Results of a double-blind, randomized, placebo-controlled trial
    • Ravindran AV, Kennedy SH, O'Donovan MC et al. Osmotic-release oral system methylphenidate augmentation of antidepressant monotherapy in major depressive disorder: results of a double-blind, randomized, placebo-controlled trial. J Clin Psychiatry 2008 69 : 87 94.
    • (2008) J Clin Psychiatry , vol.69 , pp. 87-94
    • Ravindran, A.V.1    Kennedy, S.H.2    O'Donovan, M.C.3
  • 12
    • 0031893206 scopus 로고    scopus 로고
    • Modafinil: A review of its pharmacology and clinical efficiency in the management of narcolepsy
    • Mcclelland KJ, Spencer CM. Modafinil: a review of its pharmacology and clinical efficiency in the management of narcolepsy. CNS Drugs 1998 9 : 311 324.
    • (1998) CNS Drugs , vol.9 , pp. 311-324
    • McClelland, K.J.1    Spencer, C.M.2
  • 13
    • 0035864193 scopus 로고    scopus 로고
    • Therapeutic doses of methylphenidate significantly increase extracellular dopamine in the human brain
    • Volkow ND, Wang G, Fowler JS et al. Therapeutic doses of methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci 2001 21 : RC121.
    • (2001) J Neurosci , vol.21 , pp. 121
    • Volkow, N.D.1    Wang, G.2    Fowler, J.S.3
  • 14
    • 34548030683 scopus 로고    scopus 로고
    • Differential effects of adjunctive methylphenidate and citalopram on extracellular levels of serotonin, noradrenaline and dopamine in the rat brain
    • Weikop P, Yoshitake T, Kehr J. Differential effects of adjunctive methylphenidate and citalopram on extracellular levels of serotonin, noradrenaline and dopamine in the rat brain. Eur Neuropsychopharmacology, 2007 17 : 658 671.
    • (2007) Eur Neuropsychopharmacology , vol.17 , pp. 658-671
    • Weikop, P.1    Yoshitake, T.2    Kehr, J.3
  • 15
    • 77949746084 scopus 로고    scopus 로고
    • MiMS Annual, 28th edn. MIMS Australia. Sydney
    • MiMS Annual, 28th edn. MIMS Australia, Sydney 2004.
    • (2004)
  • 16
    • 0034758620 scopus 로고    scopus 로고
    • Pharmacokinetic and pharmacodynamic drug interactions in treatment of attention-deficit hyperactivity disorder
    • Markowitz JS, Patrick KS. Pharmacokinetic and pharmacodynamic drug interactions in treatment of attention-deficit hyperactivity disorder. Clin Pharmacokinet 2001 40 : 753 772.
    • (2001) Clin Pharmacokinet , vol.40 , pp. 753-772
    • Markowitz, J.S.1    Patrick, K.S.2
  • 17
    • 0002479620 scopus 로고
    • Treatment-resistant depression
    • In. Bloom, F.E. Kupfer, D.J. eds. New York, NY. Raven Press
    • Thase ME, Rush AJ. Treatment-resistant depression. In : Bloom FE, Kupfer DJ, eds. Psychopharmacology: the fourth generation of progress. New York, NY : Raven Press, 1995 : 1081 1097.
    • (1995) Psychopharmacology: The Fourth Generation of Progress. , pp. 1081-1097
    • Thase, M.E.1    Rush, A.J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.